Comparison of the tip and supratip edema response in open and close rhinoplasty patients after intra operative injection of triamcinolone and placebo

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138905054455N1

Enrollment

Registered

2011-01-26

Start date

2009-04-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septorhinoplasty. Other disorders of the musculoskeletal system and connective tissue

Interventions

Intervention 1: Triamcinolone, 0.2 mg of 40mg/ml vial, was injected in nasal tip and supra tips area. Intervention 2: Normal Saline, with the same dose of triamsinolone, was injected in nasal tip and

Treatment - Drugs

Placebo

Triamcinolone, 0.2 mg of 40mg/ml vial, was injected in nasal tip and supra tips area.

Normal Saline, with the same dose of triamsinolone, was injected in nasal tip and supra tips area.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: age at least 18 years old, need to rhinoplasty operation, need to tip plasty, having desire to participate in trial Exclusion criteria: history op previous rhinoplasty, history of other corticosteroids use, need tip projection reduction, need to increase tip projection

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nasal tip and supra tip edema. Timepoint: first and fourth weeks after surgery. Method of measurement: obervation and checklist and rhinobase software.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026